These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26289911)

  • 1. Venous thromboembolism after total hip arthroplasty diagnosed by enhanced computed tomography:comparison of selective thromboprophylaxis and no thromboprophylaxis.
    Okada Y; Endo H; Mitani S; Fujiwara K; Tetsunaga T; Kagawa Y; Fujii Y; Kunisada T; Ozaki T
    Acta Med Okayama; 2015; 69(4):205-12. PubMed ID: 26289911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum. Venous Thromboembolism after Total Hip Arthroplasty Diagnosed by Enhanced Computed Tomography:Comparison of Selective Thromboprophylaxis and No Thromboprophylaxis.
    Okada Y; Endo H; Tanaka T; Mitani S; Fujiwara K; Tetsunaga T; Kagawa Y; Fujii Y; Kunisada T; Ozaki T
    Acta Med Okayama; 2015; 69(5):325. PubMed ID: 26490031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an Australian teaching hospital.
    Pow RE; Vale PR
    Intern Med J; 2015 Mar; 45(3):293-9. PubMed ID: 25546267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
    Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
    Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty.
    Kim SM; Moon YW; Lim SJ; Kim DW; Park YS
    Thromb Haemost; 2016 Mar; 115(3):600-7. PubMed ID: 26790579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
    Yen SH; Lin PC; Kuo FC; Wang JW
    Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
    Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
    Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty.
    Garfinkel JH; Gladnick BP; Roland N; Romness DW
    J Arthroplasty; 2018 Feb; 33(2):533-536. PubMed ID: 28947374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.
    Anderson DR; Dunbar MJ; Bohm ER; Belzile E; Kahn SR; Zukor D; Fisher W; Gofton W; Gross P; Pelet S; Crowther M; MacDonald S; Kim P; Pleasance S; Davis N; Andreou P; Wells P; Kovacs M; Rodger MA; Ramsay T; Carrier M; Vendittoli PA
    Ann Intern Med; 2013 Jun; 158(11):800-6. PubMed ID: 23732713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed?
    Malhotra K; Marciniak JL; Bonczek SJ; Hunt N
    Eur J Orthop Surg Traumatol; 2016 Dec; 26(8):895-899. PubMed ID: 27448284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?
    Bala A; Murasko MJ; Burk DR; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF
    Hip Int; 2020 Sep; 30(5):564-571. PubMed ID: 30990095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
    Fuji T; Ochi T; Niwa S; Fujita S
    J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data.
    Kim S; Ahn H; Shin SA; Park JH; Won CW
    Thromb Res; 2017 Jul; 155():48-52. PubMed ID: 28486159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
    Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
    J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group.
    Pedersen AB; Andersen IT; Overgaard S; Fenstad AM; Lie SA; Gjertsen JE; Furnes O
    Acta Orthop; 2019 Aug; 90(4):298-305. PubMed ID: 31060431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?
    Yokote R; Matsubara M; Hirasawa N; Hagio S; Ishii K; Takata C
    J Bone Joint Surg Br; 2011 Feb; 93(2):251-6. PubMed ID: 21282767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
    Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
    Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
    Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
    Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.